Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
22025
Description
Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase; ODM derived from: https://clinicaltrials.gov/show/NCT00324077
Link
https://clinicaltrials.gov/show/NCT00324077
Keywords
Versions (2)
- 5/15/17 5/15/17 -
- 5/15/17 5/15/17 -
Uploaded on
May 15, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Myeloid Leukemia, Chronic, Chronic-Phase NCT00324077
Eligibility Myeloid Leukemia, Chronic, Chronic-Phase NCT00324077
- StudyEvent: Eligibility
Similar models
Eligibility Myeloid Leukemia, Chronic, Chronic-Phase NCT00324077
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Age
Item
males and females, 18 or older
boolean
C0001779 (UMLS CUI [1])
Chronic-Phase Myeloid Leukemia Philadelphia chromosome positive | Chronic myelogenous leukemia, BCR/ABL positive
Item
chronic phase ph+ or bcr-abl positive cml
boolean
C0023474 (UMLS CUI [1,1])
C0856536 (UMLS CUI [1,2])
C1292771 (UMLS CUI [2])
C0856536 (UMLS CUI [1,2])
C1292771 (UMLS CUI [2])
imatinib | Complete Hematologic Response
Item
current complete hematologic response to imatinib
boolean
C0935989 (UMLS CUI [1])
C4050175 (UMLS CUI [2])
C4050175 (UMLS CUI [2])
Molecular Major Response Lacking
Item
lack of major molecular response
boolean
C4049637 (UMLS CUI [1,1])
C0332268 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,2])
imatinib Duration
Item
on imatinib for at least one year
boolean
C0935989 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
imatinib Dose Same Duration
Item
on the same imatinib dose for at least 6 months
boolean
C0935989 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0445247 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,4])
C0178602 (UMLS CUI [1,2])
C0445247 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,4])
Liver function | Renal function
Item
adequate hepatic and renal function
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232804 (UMLS CUI [2])
Leukemia, Myeloid, Accelerated Phase | Blast Phase
Item
history of accelerated or blast phase cml
boolean
C0023472 (UMLS CUI [1])
C0005699 (UMLS CUI [2])
C0005699 (UMLS CUI [2])
Disease Uncontrolled Serious | Communicable Disease
Item
serious uncontrolled medical disorder or active infection
boolean
C0012634 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
C0009450 (UMLS CUI [2])
C0205318 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
C0009450 (UMLS CUI [2])
Cardiovascular Disease | Blood Coagulation Disorder
Item
significant cardiovascular disease or bleeding disorder
boolean
C0007222 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
C0005779 (UMLS CUI [2])
Pharmaceutical Preparations At risk Causing Torsades de points
Item
concurrent use of medications at risk of causing torsades de pointe
boolean
C0013227 (UMLS CUI [1,1])
C1444641 (UMLS CUI [1,2])
C0678227 (UMLS CUI [1,3])
C3842160 (UMLS CUI [1,4])
C1444641 (UMLS CUI [1,2])
C0678227 (UMLS CUI [1,3])
C3842160 (UMLS CUI [1,4])